Td Asset Management Inc Novo Nordisk A S Transaction History

Td Asset Management Inc

$106 Billion
Q4 2024

A detailed history of Td Asset Management Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Td Asset Management Inc holds 598,638 shares of NVO stock, worth $54.3 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

598,638

Previous 1,020,397 41.33%

Holding current value

$54.3 Million

Previous $121 Million 57.62%

% of portfolio

0.05%

Previous 0.11%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$85.0 - $120.04 $35.8 Million - $50.6 Million	-421,759 Reduced 41.33%	598,638 $51.5 Million
Q3 2024 Nov 01, 2024	SELL	$119.07 - $145.42 $4.9 Million - $5.99 Million	-41,194 Reduced 3.88%	1,020,397 $121 Million
Q2 2024 Aug 02, 2024	SELL	$122.71 - $146.91 $1.53 Million - $1.83 Million	-12,431 Reduced 1.16%	1,061,591 $152 Million
Q1 2024 May 08, 2024	BUY	$102.11 - $135.92 $10.8 Million - $14.3 Million	105,523 Added 10.9%	1,074,022 $138 Million
Q4 2023 Feb 12, 2024	BUY	$87.78 - $105.45 $3.88 Million - $4.66 Million	44,150 Added 4.78%	968,499 $100 Million
Q3 2023 Oct 27, 2023	BUY	$90.94 - $199.54 $55.9 Million - $123 Million	614,860 Added 198.67%	924,349 $84.1 Million
Q2 2023 Aug 09, 2023	BUY	$155.98 - $172.65 $23.6 Million - $26.1 Million	151,419 Added 95.79%	309,489 $50.1 Million
Q1 2023 May 10, 2023	BUY	$132.34 - $159.14 $20.9 Million - $25.2 Million	158,070 New	158,070 $25.2 Million
Q2 2020 Aug 13, 2020	SELL	$58.54 - $67.94 $6.9 Million - $8.01 Million	-117,921 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$49.46 - $64.78 $1.07 Million - $1.4 Million	21,646 Added 22.48%	117,921 $7.1 Million
Q4 2019 Feb 11, 2020	BUY	$49.86 - $58.26 $182,687 - $213,464	3,664 Added 3.96%	96,275 $5.57 Million
Q3 2019 Nov 07, 2019	BUY	$47.54 - $53.43 $297,267 - $334,097	6,253 Added 7.24%	92,611 $4.79 Million
Q2 2019 Aug 01, 2019	BUY	$46.79 - $52.47 $263,474 - $295,458	5,631 Added 6.98%	86,358 $4.41 Million
Q1 2019 May 08, 2019	BUY	$46.36 - $52.63 $279,782 - $317,622	6,035 Added 8.08%	80,727 $4.22 Million
Q4 2018 Feb 01, 2019	SELL	$41.54 - $47.25 $475,840 - $541,248	-11,455 Reduced 13.3%	74,692 $3.44 Million
Q3 2018 Nov 01, 2018	BUY	$46.76 - $51.24 $420,652 - $460,955	8,996 Added 11.66%	86,147 $4.06 Million
Q2 2018 Jul 31, 2018	SELL	$44.29 - $50.42 $118,342 - $134,722	-2,672 Reduced 3.35%	77,151 $3.56 Million
Q1 2018 May 11, 2018	BUY	$48.49 - $58.14 $221,017 - $265,002	4,558 Added 6.06%	79,823 $3.93 Million
Q4 2017 Feb 02, 2018	BUY	$47.53 - $53.73 $381,048 - $430,753	8,017 Added 11.92%	75,265 $4.04 Million
Q3 2017 Nov 09, 2017	BUY	$41.15 - $49.22 $2.77 Million - $3.31 Million	67,248	67,248 $3.24 Million

Others Institutions Holding NVO

# of Institutions

1,884

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $205B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Novo Nordisk A S Transaction History